SG10201804306VA - THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS - Google Patents

THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

Info

Publication number
SG10201804306VA
SG10201804306VA SG10201804306VA SG10201804306VA SG10201804306VA SG 10201804306V A SG10201804306V A SG 10201804306VA SG 10201804306V A SG10201804306V A SG 10201804306VA SG 10201804306V A SG10201804306V A SG 10201804306VA SG 10201804306V A SG10201804306V A SG 10201804306VA
Authority
SG
Singapore
Prior art keywords
thieno
viral infections
treatment
pyrimidines derivatives
pyrimidines
Prior art date
Application number
SG10201804306VA
Inventor
Gowan David Craig Mc
Pierre Jean-Marie Bernard Raboisson
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of SG10201804306VA publication Critical patent/SG10201804306VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS This invention relates to thieno[3,2-d]pyrimidines derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections. [No available fig.]
SG10201804306VA 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS SG10201804306VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13178534 2013-07-30

Publications (1)

Publication Number Publication Date
SG10201804306VA true SG10201804306VA (en) 2018-06-28

Family

ID=48874951

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201804306VA SG10201804306VA (en) 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
SG11201510736PA SG11201510736PA (en) 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201510736PA SG11201510736PA (en) 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

Country Status (21)

Country Link
US (3) US9556199B2 (en)
EP (2) EP3027624B1 (en)
JP (1) JP6401788B2 (en)
KR (1) KR102322425B1 (en)
CN (2) CN108912137B (en)
AU (2) AU2014298540B2 (en)
BR (1) BR112016001570B1 (en)
CA (1) CA2913691C (en)
CL (1) CL2015003767A1 (en)
DK (2) DK3404031T3 (en)
EA (1) EA036162B1 (en)
ES (2) ES2701239T3 (en)
HK (1) HK1217707A1 (en)
IL (2) IL242872B (en)
MX (1) MX368625B (en)
MY (1) MY179503A (en)
PH (1) PH12015502797B1 (en)
SG (2) SG10201804306VA (en)
UA (1) UA117253C2 (en)
WO (1) WO2015014815A1 (en)
ZA (1) ZA201600655B (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122017025423B1 (en) 2011-04-08 2021-05-11 Janssen Sciences Ireland Uc pyrimidine derivatives, their use in the treatment of viral infections and pharmaceutical composition comprising them
BR122019020718B1 (en) 2011-11-09 2021-07-06 Janssen Sciences Ireland Uc PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND THE PHARMACEUTICAL COMPOSITION INCLUDING THEM
NZ702364A (en) 2012-07-13 2016-09-30 Janssen Sciences Ireland Uc Macrocyclic purines for the treatment of viral infections
JP6293765B2 (en) 2012-10-10 2018-03-14 ヤンセン・サイエンシズ・アイルランド・ユーシー Pyrrolo [3,2-D] pyrimidine derivatives for the treatment of viral infections and other diseases
BR112015011036B1 (en) 2012-11-16 2022-02-01 Janssen Sciences Ireland Uc Heterocyclic Substituted 2-Amino-quinazoline Derivatives, Pharmaceutical Composition
EA035174B1 (en) 2013-02-21 2020-05-12 Янссен Сайенсиз Айрлэнд Юси 2-aminopyrimidine derivatives as modulators of toll-like receptors tlr7 and/or tlr8
SG11201508078XA (en) 2013-03-29 2015-11-27 Janssen Sciences Ireland Uc Macrocyclic deaza-purinones for the treatment of viral infections
KR102280559B1 (en) 2013-05-24 2021-07-22 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 Pyridone derivatives for the treatment of viral infections and further diseases
ES2645950T3 (en) 2013-06-27 2017-12-11 Janssen Sciences Ireland Uc Pyrrolo [3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases
JP6401788B2 (en) * 2013-07-30 2018-10-10 ヤンセン・サイエンシズ・アイルランド・ユーシー Thieno [3,2-d] pyrimidine derivatives for viral infection treatment
CN107108615B (en) 2015-03-04 2020-11-20 吉利德科学公司 Toll-like receptor modulating 4, 6-diamino-pyrido [3,2-D ] pyrimidine compounds
JP7171444B2 (en) 2016-07-01 2022-11-15 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー Dihydropyranopyrimidines for treating viral infections
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
EP3507276B1 (en) 2016-09-02 2021-11-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
KR102450287B1 (en) 2016-09-29 2022-09-30 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 Pyrimidine prodrugs for treatment of viral infections and additional diseases
DK3526323T3 (en) 2016-10-14 2023-06-26 Prec Biosciences Inc MODIFIED MEGANUCLEASES SPECIFIC FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME
WO2019084060A1 (en) 2017-10-24 2019-05-02 Silverback Therapeutics, Inc. Conjugates and methods of use thereof for selective delivery of immune-modulatory agents
CA3084667A1 (en) 2017-12-15 2019-06-20 Silverback Therapeutics, Inc. Antibody construct-drug conjugate for the treatment of hepatitis
EP3728283B1 (en) 2017-12-20 2023-11-22 Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. 3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
AU2018392212B9 (en) 2017-12-20 2021-03-18 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
CN111788204B (en) 2018-02-26 2023-05-05 吉利德科学公司 Substituted pyrrolizine compounds as inhibitors of HBV replication
TW201945003A (en) 2018-03-01 2019-12-01 愛爾蘭商健生科學愛爾蘭無限公司 2,4-diaminoquinazoline derivatives and medical uses thereof
TWI793294B (en) * 2018-04-03 2023-02-21 美商默沙東有限責任公司 Sting agonist compounds
US10870691B2 (en) 2018-04-05 2020-12-22 Gilead Sciences, Inc. Antibodies and fragments thereof that bind hepatitis B virus protein X
TWI818007B (en) 2018-04-06 2023-10-11 捷克科學院有機化學與生物化學研究所 2'3'-cyclic dinucleotides
TW202005654A (en) 2018-04-06 2020-02-01 捷克科學院有機化學與生物化學研究所 2'2'-cyclic dinucleotides
TWI833744B (en) 2018-04-06 2024-03-01 捷克科學院有機化學與生物化學研究所 3'3'-cyclic dinucleotides
TW201945388A (en) 2018-04-12 2019-12-01 美商精密生物科學公司 Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis B virus genome
WO2019211799A1 (en) 2018-05-03 2019-11-07 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
WO2020028097A1 (en) 2018-08-01 2020-02-06 Gilead Sciences, Inc. Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
CN113164618A (en) 2018-09-12 2021-07-23 希沃尔拜克治疗公司 Methods and compositions for treating diseases with immunostimulatory conjugates
JP7460644B2 (en) 2018-10-31 2024-04-02 ギリアード サイエンシーズ， インコーポレイテッド Substituted 6-Azabenzimidazole Compounds as HPK1 Inhibitors
WO2020092528A1 (en) 2018-10-31 2020-05-07 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
MX2021009496A (en) 2019-02-08 2021-09-08 Progeneer Inc Toll-like receptor 7 or 8 agonist-cholesterol complex, and use of same.
AU2020231115A1 (en) 2019-03-07 2021-08-26 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 3'3'-cyclic dinucleotides and prodrugs thereof
EP3934757B1 (en) 2019-03-07 2023-02-22 Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. 2'3'-cyclic dinucleotides and prodrugs thereof
EP3935065A1 (en) 2019-03-07 2022-01-12 Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. 3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
TW202212339A (en) 2019-04-17 2022-04-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TW202210480A (en) 2019-04-17 2022-03-16 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI826690B (en) 2019-05-23 2023-12-21 美商基利科學股份有限公司 Substituted eneoxindoles and uses thereof
MX2021015533A (en) 2019-06-19 2022-02-10 Silverback Therapeutics Inc Anti-mesothelin antibodies and immunoconjugates thereof.
TW202115056A (en) 2019-06-28 2021-04-16 美商基利科學股份有限公司 Processes for preparing toll-like receptor modulator compounds
EP4017476A1 (en) 2019-08-19 2022-06-29 Gilead Sciences, Inc. Pharmaceutical formulations of tenofovir alafenamide
WO2021057256A1 (en) * 2019-09-29 2021-04-01 四川科伦博泰生物医药股份有限公司 Heterocyclic nitrogen compound, pharmaceutical composition containing same, preparation method therefor and use thereof
CA3149557A1 (en) 2019-09-30 2021-04-08 Scott J. Balsitis Hbv vaccines and methods treating hbv
WO2021067644A1 (en) 2019-10-01 2021-04-08 Silverback Therapeutics, Inc. Combination therapy with immune stimulatory conjugates
CN116057068A (en) 2019-12-06 2023-05-02 精密生物科学公司 Optimized engineered meganucleases with specificity for recognition sequences in hepatitis b virus genomes
WO2021168274A1 (en) 2020-02-21 2021-08-26 Silverback Therapeutics, Inc. Nectin-4 antibody conjugates and uses thereof
CN115666637A (en) 2020-03-02 2023-01-31 蛋白科技先锋 Nano particle simulating live pathogen based on pathogen cell wall skeleton and preparation method thereof
AU2021237718B2 (en) 2020-03-20 2023-09-21 Gilead Sciences, Inc. Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
JP2023532304A (en) 2020-07-01 2023-07-27 エーアールエス ファーマシューティカルズ オペレーションズ，インク． Anti-ASGR1 antibody conjugates and uses thereof
JP2023536954A (en) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド Conjugate of Toll-like Receptor 7 or 8 Agonist with Temporarily Inactivated Activation Site and Functional Drug, and Use of the Same
US20230346924A1 (en) 2020-08-04 2023-11-02 Progeneer Inc. Mrna vaccine comprising adjuvant capable of kinetic control
US20230355750A1 (en) 2020-08-04 2023-11-09 Progeneer Inc. Kinetically acting adjuvant ensemble
CA3215049A1 (en) 2021-04-10 2022-10-13 Baiteng ZHAO Folr1 binding agents, conjugates thereof and methods of using the same
TW202308699A (en) 2021-04-23 2023-03-01 美商普方生物製藥美國公司 Cd70 binding agents, conjugates thereof and methods of using the same
AU2022274607A1 (en) 2021-05-13 2023-11-16 Gilead Sciences, Inc. COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
CN117480155A (en) 2021-06-23 2024-01-30 吉利德科学公司 Diacylglycerol kinase modulating compounds
CA3222439A1 (en) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
WO2022271650A1 (en) 2021-06-23 2022-12-29 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
EP4359415A1 (en) 2021-06-23 2024-05-01 Gilead Sciences, Inc. Diacylglyercol kinase modulating compounds
TW202320857A (en) 2021-07-06 2023-06-01 美商普方生物製藥美國公司 Linkers, drug linkers and conjugates thereof and methods of using the same

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2610889B2 (en) 1987-09-03 1997-05-14 日本臓器製薬株式会社 New crosslinked adenine derivatives
NZ329798A (en) 1996-07-03 1999-04-29 Japan Energy Corp Purine derivatives their tautomers and salts thereof and interferon secretion inducers, antiviral agents and anticancer drugs containing the same
CA2263566C (en) 1996-08-28 2003-09-09 Pfizer Inc. Substituted 6,5-hetero-bicyclic derivatives
WO1998014448A1 (en) 1996-10-04 1998-04-09 Kyorin Pharmaceutical Co., Ltd. Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof
AR012634A1 (en) 1997-05-02 2000-11-08 Sugen Inc QUINAZOLINE BASED COMPOUND, FAMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, METHOD TO SYNTHESIZE IT, ITS USE, METHODS OF MODULATION OF THE DESERINE / TREONIN PROTEIN-KINASE FUNCTION AND IN VITRO METHOD TO IDENTIFY COMPOUNDS THAT MODULATE
US6339089B2 (en) * 1997-08-13 2002-01-15 Fujirebio Inc. Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
AU732361B2 (en) 1997-11-28 2001-04-26 Dainippon Sumitomo Pharma Co., Ltd. Novel heterocyclic compounds
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
NZ506417A (en) 1998-02-17 2003-05-30 Tularik Inc Anti-viral pyrimidine derivatives
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
JP4315300B2 (en) 1998-08-10 2009-08-19 大日本住友製薬株式会社 Novel quinazoline derivatives
JP4342007B2 (en) 1998-08-10 2009-10-14 大日本住友製薬株式会社 Quinazoline derivatives
ATE267175T1 (en) 1998-08-27 2004-06-15 Sumitomo Pharma PYRIMIDINE DERIVATIVES
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
CA2323008C (en) 1999-10-11 2005-07-12 Pfizer Inc. Pharmaceutically active compounds
WO2002088079A2 (en) 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
AU2002364211A1 (en) * 2001-12-21 2003-07-15 Bayer Pharmaceuticals Corporation Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
US7091232B2 (en) 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
TW200407143A (en) 2002-05-21 2004-05-16 Bristol Myers Squibb Co Pyrrolotriazinone compounds and their use to treat diseases
JPWO2003104230A1 (en) 2002-06-07 2005-10-06 協和醗酵工業株式会社 Bicyclic pyrimidine derivatives
BR0314761A (en) 2002-09-27 2005-07-26 Sumitomo Pharma Adenine Compound and its Use
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
BRPI0411514A (en) 2003-06-20 2006-08-01 Coley Pharm Gmbh small molecule toll-like receptor antagonists
BRPI0414045A (en) 2003-09-05 2006-10-24 Anadys Pharmaceuticals Inc administration of tlr7 ligands and prodrugs thereof for the treatment of hepatitis C virus infection
EP1728793B1 (en) 2004-03-26 2016-02-03 Sumitomo Dainippon Pharma Co., Ltd. 9-substituted 8-oxoadenine compound
WO2005092892A1 (en) 2004-03-26 2005-10-06 Dainippon Sumitomo Pharma Co., Ltd. 8-oxoadenine compound
WO2007084413A2 (en) 2004-07-14 2007-07-26 Ptc Therapeutics, Inc. Methods for treating hepatitis c
CA2575002C (en) 2004-08-10 2015-01-20 Janssen Pharmaceutica N.V. Hiv inhibiting 1,2,4-triazin-6-one derivatives
EP1812409A1 (en) 2004-11-09 2007-08-01 F. Hoffmann-Roche AG Aminoquinazolines compounds
US7498409B2 (en) 2005-03-24 2009-03-03 Schering Corporation Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
WO2006117670A1 (en) 2005-05-04 2006-11-09 Pfizer Limited 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
TW200716631A (en) 2005-05-12 2007-05-01 Tibotec Pharm Ltd Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
US7994360B2 (en) 2005-05-16 2011-08-09 Xtl Biopharmaceuticals Ltd. Benzofuran compounds
CA2619919C (en) 2005-09-01 2014-04-01 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
EP1939198A4 (en) 2005-09-22 2012-02-15 Dainippon Sumitomo Pharma Co Novel adenine compound
US20070099941A1 (en) * 2005-11-02 2007-05-03 Cytovia, Inc. N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US20090182140A1 (en) 2005-12-02 2009-07-16 Mitsubishi Tanabe Pharma Corporation Alicyclic Heterocyclic Compound
CA2640672A1 (en) 2006-02-17 2007-08-23 Pfizer Limited 3 -deazapurine derivatives as tlr7 modulators
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
WO2008009077A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
US9487533B2 (en) * 2006-12-07 2016-11-08 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and methods of use
CN103224506A (en) 2006-12-20 2013-07-31 P.安杰莱蒂分子生物学研究所 Antiviral indoles
CA2677733A1 (en) 2007-02-07 2008-09-25 The Regents Of The University Of California Conjugates of synthetic tlr agonists and uses therefor
JP2008222557A (en) 2007-03-08 2008-09-25 Kotobuki Seiyaku Kk PYRROLO[3,2-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS EFFECTIVE COMPONENT
ES2457316T3 (en) 2007-03-19 2014-04-25 Astrazeneca Ab 8-Oxo-adenine 9 compounds substituted as toll-like receptor modulators (TLR7)
US8044056B2 (en) 2007-03-20 2011-10-25 Dainippon Sumitomo Pharma Co., Ltd. Adenine compound
AR065784A1 (en) 2007-03-20 2009-07-01 Dainippon Sumitomo Pharma Co DERIVATIVES OF 8-OXO ADENINE, DRUGS THAT CONTAIN THEM AND USES AS THERAPEUTIC AGENTS FOR ALLERGIC, ANTIVIRAL OR ANTIBACTERIAL DISEASES.
CA2687821C (en) 2007-05-22 2015-04-14 Boehringer Ingelheim International Gmbh Benzimidazolone chymase inhibitors
EA024359B1 (en) 2007-06-29 2016-09-30 Джилид Сайэнс, Инк. Purine derivatives and their use as modulators of toll-like receptor 7
AU2008287421A1 (en) 2007-08-10 2009-02-19 Glaxosmithkline Llc Nitrogen containing bicyclic chemical entities for treating viral infections
CA2696824A1 (en) 2007-08-28 2009-03-12 Irm Llc Compounds and compositions as kinase inhibitors
WO2009030998A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Pyrimidine compounds as toll-like receptor (tlr) agonists
PE20091236A1 (en) 2007-11-22 2009-09-16 Astrazeneca Ab PYRIMIDINE DERIVATIVES AS IMMUNOMODULATORS OF TLR7
WO2009080836A2 (en) 2007-12-24 2009-07-02 Tibotec Pharmaceuticals Ltd. Macrocyclic indoles as hepatitis c virus inhibitors
KR20100137449A (en) 2008-02-07 2010-12-30 더 리전트 오브 더 유니버시티 오브 캘리포니아 Treatment of bladder diseases with a tlr7 activator
US8466167B2 (en) * 2008-03-03 2013-06-18 Irm Llc Compounds and compositions as TLR activity modulators
US8461107B2 (en) 2008-04-28 2013-06-11 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
US8946239B2 (en) 2008-07-10 2015-02-03 Duquesne University Of The Holy Spirit Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
UY31982A (en) 2008-07-16 2010-02-26 Boehringer Ingelheim Int DERIVATIVES OF 1,2-DIHYDROPIRIDIN-3-CARBOXAMIDS N-SUBSTITUTED
SG175796A1 (en) 2009-05-21 2011-12-29 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
TWI468402B (en) 2009-07-31 2015-01-11 必治妥美雅史谷比公司 Compounds for the reduction of β-amyloid production
US8637525B2 (en) 2009-07-31 2014-01-28 Bristol-Myers Squibb Company Compounds for the reduction of beta-amyloid production
WO2011049988A2 (en) 2009-10-20 2011-04-28 Eiger Biopharmaceuticals, Inc. Indazoles to treat flaviviridae virus infection
EP2491035B1 (en) 2009-10-22 2017-08-30 Gilead Sciences, Inc. Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
KR101094446B1 (en) 2009-11-19 2011-12-15 한국과학기술연구원 2,4,7-Substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors
JP2013032290A (en) 2009-11-20 2013-02-14 Dainippon Sumitomo Pharma Co Ltd Novel fused pyrimidine derivative
DE102010040233A1 (en) 2010-09-03 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Bicyclic aza heterocycles and their use
WO2012066335A1 (en) 2010-11-19 2012-05-24 Astrazeneca Ab Phenol compounds als toll -like receptor 7 agonists
WO2012067269A1 (en) 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease
EP2691156A1 (en) * 2011-03-30 2014-02-05 Boehringer Ingelheim International GmbH Anticoagulant antidotes
BR122017025423B1 (en) 2011-04-08 2021-05-11 Janssen Sciences Ireland Uc pyrimidine derivatives, their use in the treatment of viral infections and pharmaceutical composition comprising them
US8916575B2 (en) 2011-05-18 2014-12-23 Janssen R&D Ireland Quinazoline derivatives for the treatment of viral infections and further diseases
BR122019020718B1 (en) 2011-11-09 2021-07-06 Janssen Sciences Ireland Uc PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND THE PHARMACEUTICAL COMPOSITION INCLUDING THEM
EP2812331B1 (en) 2012-02-08 2019-01-02 Janssen Sciences Ireland Unlimited Company Piperidino-pyrimidine derivatives for the treatment of viral infections
PT2841428T (en) 2012-04-24 2018-11-29 Vertex Pharma Dna-pk inhibitors
NZ702364A (en) 2012-07-13 2016-09-30 Janssen Sciences Ireland Uc Macrocyclic purines for the treatment of viral infections
EA029266B1 (en) 2012-08-10 2018-02-28 Янссен Сайенсиз Айрлэнд Юси Alkylpyrimidine derivatives for the treatment of viral infections
EP2712866A1 (en) 2012-10-01 2014-04-02 Centre National de la Recherche Scientifique (CNRS) 1,2,4-triazine derivatives for the treatment of viral infections
BR112015007366A2 (en) 2012-10-05 2017-07-04 Janssen Sciences Ireland Uc acylaminopyrimidine derivatives for the treatment of viral infections and other diseases
JP6293765B2 (en) 2012-10-10 2018-03-14 ヤンセン・サイエンシズ・アイルランド・ユーシー Pyrrolo [3,2-D] pyrimidine derivatives for the treatment of viral infections and other diseases
BR112015011036B1 (en) 2012-11-16 2022-02-01 Janssen Sciences Ireland Uc Heterocyclic Substituted 2-Amino-quinazoline Derivatives, Pharmaceutical Composition
EA035174B1 (en) 2013-02-21 2020-05-12 Янссен Сайенсиз Айрлэнд Юси 2-aminopyrimidine derivatives as modulators of toll-like receptors tlr7 and/or tlr8
SG11201508078XA (en) 2013-03-29 2015-11-27 Janssen Sciences Ireland Uc Macrocyclic deaza-purinones for the treatment of viral infections
JP6401788B2 (en) * 2013-07-30 2018-10-10 ヤンセン・サイエンシズ・アイルランド・ユーシー Thieno [3,2-d] pyrimidine derivatives for viral infection treatment
US9701661B2 (en) 2014-07-11 2017-07-11 Northwestern University 2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

Also Published As

Publication number Publication date
CL2015003767A1 (en) 2016-07-08
KR102322425B1 (en) 2021-11-05
DK3404031T3 (en) 2020-12-14
IL266897B (en) 2020-11-30
MX368625B (en) 2019-10-08
AU2018256591B2 (en) 2020-03-19
BR112016001570B1 (en) 2020-12-15
IL266897A (en) 2019-07-31
ES2701239T3 (en) 2019-02-21
CN105492446A (en) 2016-04-13
CN108912137A (en) 2018-11-30
EP3027624B1 (en) 2018-09-12
KR20160035583A (en) 2016-03-31
AU2018256591A1 (en) 2018-11-22
AU2014298540A1 (en) 2015-12-17
US10822347B2 (en) 2020-11-03
EA036162B1 (en) 2020-10-08
CA2913691A1 (en) 2015-02-05
WO2015014815A1 (en) 2015-02-05
PH12015502797A1 (en) 2016-03-14
EP3404031A1 (en) 2018-11-21
IL242872B (en) 2019-06-30
SG11201510736PA (en) 2016-02-26
UA117253C2 (en) 2018-07-10
DK3027624T3 (en) 2019-01-07
CN105492446B (en) 2018-08-03
CN108912137B (en) 2021-04-09
US20160168164A1 (en) 2016-06-16
EP3404031B1 (en) 2020-09-23
NZ714519A (en) 2021-07-30
US10316043B2 (en) 2019-06-11
US9556199B2 (en) 2017-01-31
MX2016001464A (en) 2016-06-02
IL242872A0 (en) 2016-02-01
HK1217707A1 (en) 2017-01-20
MY179503A (en) 2020-11-09
EP3027624A1 (en) 2016-06-08
US20190330227A1 (en) 2019-10-31
JP6401788B2 (en) 2018-10-10
AU2014298540B2 (en) 2018-08-09
US20170298079A1 (en) 2017-10-19
ZA201600655B (en) 2022-03-30
CA2913691C (en) 2022-01-25
JP2016525148A (en) 2016-08-22
PH12015502797B1 (en) 2016-03-14
EA201690303A1 (en) 2016-06-30
ES2836881T3 (en) 2021-06-28

Similar Documents

Publication Publication Date Title
AU2018256591A1 (en) Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12015502780A1 (en) Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
PH12015502261A1 (en) Macrocyclic deaza-purinones for the treatment of viral infections
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500758A1 (en) Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12015502564B1 (en) Pyridone derivatives for the treatment of viral infections and further diseases